-
Je něco špatně v tomto záznamu ?
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol
R. Prymula, A. Habib, N. François, D. Borys, L. Schuerman,
Jazyk angličtina Země Nizozemsko
Typ dokumentu klinické zkoušky kontrolované, časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 2002-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2002-01-01 do Před 2 měsíci
Family Health Database (ProQuest)
od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest)
od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2002-01-01 do Před 2 měsíci
- MeSH
- bakteriální proteiny imunologie MeSH
- Haemophilus influenzae chemie imunologie MeSH
- imunologická paměť imunologie MeSH
- lidé MeSH
- nazofarynx imunologie MeSH
- paracetamol aplikace a dávkování MeSH
- pneumokokové infekce imunologie prevence a kontrola MeSH
- pneumokokové vakcíny aplikace a dávkování škodlivé účinky imunologie MeSH
- předškolní dítě MeSH
- protilátky bakteriální imunologie MeSH
- sekundární imunizace * MeSH
- vakcinace MeSH
- vakcíny konjugované aplikace a dávkování škodlivé účinky imunologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky kontrolované MeSH
- práce podpořená grantem MeSH
BACKGROUND: Prophylactic paracetamol (PP) was previously shown to reduce primary and booster antibody responses against the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). This study further evaluated the effect of PP on antibody persistence, immunological memory and nasopharyngeal carriage (NPC). METHODS: Two hundred and twenty children previously primed (3 doses, NCT00370318) and boosted (NCT00496015) with PHiD-CV with (PP group) or without (NPP group) prophylactic paracetamol administration received one PHiD-CV dose in their fourth year of life to assess the induction of immunological memory following previous immunisations. A control group of age-matched unprimed children enrolled in study NCT00496015 received an investigational tetravalent Neisseria meningitidis serogroups A, C, W-135, Y tetanus toxoid-conjugate vaccine, and thus remained unprimed for pneumococcal vaccination. Of these, 223 unprimed children received in the present study at least one PHiD-CV dose of a 2-dose catch-up regimen, which was relevant as control for assessment of immunological memory in PHiD-CV primed children. RESULTS: Induction of immunological memory was shown irrespective of PP administration at primary and booster vaccination. Antibody geometric mean concentrations were lower in the PP group for serotypes 1, 4, 7F and 9V. Opsonophagocytic titres did not differ significantly between PP and NPP groups. Previous use of PP seemed to have only a minor impact on kinetics of antibody persistence. Reduced NPC of vaccine pneumococcal serotypes and trends towards increased NPC of non-vaccine and non-cross-reactive serotypes were seen in primed groups versus the control group, with no obvious differences between PP and NPP groups. CONCLUSION: Regardless of whether previous PHiD-CV vaccination was given with or without PP, induction of immunological memory and persistence of PHiD-CV's impact on carriage was seen until at least 28 months post-booster vaccination. Our study results therefore suggest that the lower immune responses after primary and booster vaccination with PP are of transient nature.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051193
- 003
- CZ-PrNML
- 005
- 20140410103700.0
- 007
- ta
- 008
- 140401s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vaccine.2013.01.044 $2 doi
- 035 __
- $a (PubMed)23391599
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Prymula, Roman
- 245 10
- $a Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol / $c R. Prymula, A. Habib, N. François, D. Borys, L. Schuerman,
- 520 9_
- $a BACKGROUND: Prophylactic paracetamol (PP) was previously shown to reduce primary and booster antibody responses against the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). This study further evaluated the effect of PP on antibody persistence, immunological memory and nasopharyngeal carriage (NPC). METHODS: Two hundred and twenty children previously primed (3 doses, NCT00370318) and boosted (NCT00496015) with PHiD-CV with (PP group) or without (NPP group) prophylactic paracetamol administration received one PHiD-CV dose in their fourth year of life to assess the induction of immunological memory following previous immunisations. A control group of age-matched unprimed children enrolled in study NCT00496015 received an investigational tetravalent Neisseria meningitidis serogroups A, C, W-135, Y tetanus toxoid-conjugate vaccine, and thus remained unprimed for pneumococcal vaccination. Of these, 223 unprimed children received in the present study at least one PHiD-CV dose of a 2-dose catch-up regimen, which was relevant as control for assessment of immunological memory in PHiD-CV primed children. RESULTS: Induction of immunological memory was shown irrespective of PP administration at primary and booster vaccination. Antibody geometric mean concentrations were lower in the PP group for serotypes 1, 4, 7F and 9V. Opsonophagocytic titres did not differ significantly between PP and NPP groups. Previous use of PP seemed to have only a minor impact on kinetics of antibody persistence. Reduced NPC of vaccine pneumococcal serotypes and trends towards increased NPC of non-vaccine and non-cross-reactive serotypes were seen in primed groups versus the control group, with no obvious differences between PP and NPP groups. CONCLUSION: Regardless of whether previous PHiD-CV vaccination was given with or without PP, induction of immunological memory and persistence of PHiD-CV's impact on carriage was seen until at least 28 months post-booster vaccination. Our study results therefore suggest that the lower immune responses after primary and booster vaccination with PP are of transient nature.
- 650 _2
- $a paracetamol $x aplikace a dávkování $7 D000082
- 650 _2
- $a protilátky bakteriální $x imunologie $7 D000907
- 650 _2
- $a bakteriální proteiny $x imunologie $7 D001426
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a Haemophilus influenzae $x chemie $x imunologie $7 D006193
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a sekundární imunizace $7 D007117
- 650 _2
- $a imunologická paměť $x imunologie $7 D007156
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nazofarynx $x imunologie $7 D009305
- 650 _2
- $a pneumokokové infekce $x imunologie $x prevence a kontrola $7 D011008
- 650 _2
- $a pneumokokové vakcíny $x aplikace a dávkování $x škodlivé účinky $x imunologie $7 D022242
- 650 _2
- $a vakcinace $7 D014611
- 650 _2
- $a vakcíny konjugované $x aplikace a dávkování $x škodlivé účinky $x imunologie $7 D018074
- 655 _2
- $a klinické zkoušky kontrolované $7 D018848
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Habib, Ahsan $u -
- 700 1_
- $a François, Nancy $u -
- 700 1_
- $a Borys, Dorota $u -
- 700 1_
- $a Schuerman, Lode $u -
- 773 0_
- $w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 31, č. 16 (2013), s. 2080-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23391599 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140410103749 $b ABA008
- 999 __
- $a ok $b bmc $g 1018329 $s 849773
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 31 $c 16 $d 2080-8 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
- LZP __
- $a Pubmed-20140401